SCHEMBL4378158

SCHEMBL4378158

Nc1nc2ccncc2c2[nH]cnc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 3/20 0.40
KDM4A O75164 1/20 0.38
KDM4B O94953 1/20 0.38
KDM5C P41229 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
KDM5B Q9UGL1 1/20 0.38
KDM3A Q9Y4C1 1/20 0.38
DYRK1A Q13627 2/20 0.37
PDPK1 O15530 1/20 0.34
GDA Q9Y2T3 1/20 0.34
TBK1 Q9UHD2 1/20 0.34
RPS6KA5 O75582 1/20 0.32
MAPK10 P53779 1/20 0.32
NFATC1 O95644 1/20 0.32
GSK3B P49841 1/20 0.32
CDK5 Q00535 1/20 0.32
CDK5R1 Q15078 1/20 0.32
KDM4E B2RXH2 1/20 0.32
POLB P06746 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3352424 0.88 KDM4C (0.45) CLK1KDM4AKDM4BKDM5CKDM4C
SCHEMBL212131 0.79 TLR7 (0.44) PDPK1KDM4EPOLBHTTRAD52
SCHEMBL29694218 0.79 TLR7 (0.44) PDPK1KDM4EPOLBHTTRAD52
Hydrochloric Acid SCHEMBL5523405 0.78 RAB9A (0.44) PDPK1KDM4EPOLBHTTRAD52
Hydrochloric Acid SCHEMBL10587438 0.76 ALDH1A1 (0.46) PDPK1KDM4EPOLBHTTRAD52
SCHEMBL5371096 0.76 PDPK1 (0.42) KDM4AKDM4BKDM5CKDM4CKDM5B
SCHEMBL28312743 0.75 TLR7 (0.44) KDM4EPOLBLMNA
SCHEMBL3516564 0.74 QPCT (0.50) DYRK1ATBK1GSK3BCDK5HTT
SCHEMBL4382959 0.74 CLK1 (0.36) CLK1KDM4AKDM4CDYRK1ARPS6KA5
SCHEMBL17969621 0.73 KDM4A (0.44) CLK1KDM4AKDM4BKDM5CKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329721-B2 Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-12-11 US disclosed
US-20090298821-A1 HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS PFIZER INC. 2009-12-03 US disclosed
WO-2007143526-A2 SUBSTITUTED TETRAHYDROIMIDAZONAPHTHYRIDINES AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-12-13 WO disclosed
WO-2007106854-A2 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZONAPHTHYRIDINES AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298821-A1 HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS IL2, IL4, IFNG CLK1 4821/4885KDM4A 2134/4885KDM4B 2669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.